US market concentration: Risks, diversification and what it means for investors

Geometric architectural pattern illustrating structural concentration and repetition

5min read

Please sign up to receive insights, publications and updates from our experts.

The dominance of the global capital markets and the U.S. stock markets in particular, by a handful of companies including the so-called “Magnificent Seven”  trillion dollar tech companies, raises questions about risk, diversification, and long-term strategy for investors.

Will Godsave discusses why US market concentration requires investors to take a thoughtful approach to better navigate market swings, avoid concentration risk and pursue long term outcomes within a more evidence-based framework.

US market concentration has reached levels not seen since the late 1990s, raising important questions for investors around risk, diversification and portfolio construction. As of early 2026, the top ten US stocks account for over a third of the S&P 500 market capitalisation, a level comparable to the dotcom era, albeit with some rotation beneath the surface in recent months. While the leading stocks have  broadened slightly, mega cap technology companies led by Apple, Microsoft, Nvidia and Alphabet continue to play a dominant role, supported by ongoing enthusiasm around AI and longer-term shifts.

Such a high level of concentration can be beneficial. These companies have powered a significant portion of gains in the S&P 500 over the last decade, bolstering overall investor returns and shaping sentiment across global markets. With the US representing about 65% of global equity market capitalisation, movements in this relatively small group of companies reverberate far beyond their domestic borders. For many investors, this concentration is not a deliberate choice, but a byproduct of tracking traditional market cap weighted indices.

Why elevated US market concentration is a double‑edged sword

History shows that periods of extreme market concentration tend to be a double-edged sword. Highly concentrated markets have often delivered strong headline returns, but those gains are typically driven by a very small number of companies. Long term evidence from US equities illustrates that only a minority of stocks are responsible for the majority of total shareholder wealth created over time, while the average stock delivers far more modest outcomes.

This dynamic matters because concentration amplifies both upside and downside. When the number of leading stocks remains narrow, index returns can look healthy even as participation across the broader market weakens. The late 1990s dotcom boom is a clear example. Market concentration magnified gains on the way up, but left investors heavily exposed when stocks faltered, and valuations reset. Today’s environment, while structurally different, echoes many of those same characteristics..

Why market concentration matters for investors today

Context is important. Market cap concentration naturally fluctuates over time. There have been periods when large-cap companies dominate returns, and others where smaller companies, often overlooked in traditional indices, lead the way. Over full market cycles, equally weighted approaches have historically modestly outperformed market cap weighted indices, capturing a combination of smaller cap, value and systematic rebalancing premiums that traditional weighting overlooks.

For investors, this insight is particularly relevant during periods of elevated concentration. Relying solely on market cap indices can create unintended exposure to a narrow set of outcomes. Incorporating an equal weighted allocation offers a structured way to reduce concentration risk, help smooth return paths and maintain exposure to a broader opportunity set, particularly if and when today’s market leadership begins to unwind.

Key takeaways for investors facing high market concentration

High concentration in US equities is not inherently negative, but it does require a thoughtful approach. The market’s current structure highlights both the potential rewards and the inherent risks of relying on a relatively small number of dominant companies. By combining different methods of market exposure, balancing market cap leadership with equal weighted diversification, investors can better navigate market swings, reduce concentration risk, and pursue long-term outcomes within a more evidence-based framework.

How PKF can help investors navigate market concentration

Through our partnership with Credo, our Private Client team take a joined‑up approach to tax and financial planning, helping investors to navigate market concentration and achieve their long-term goals. Please contact, Private Client Tax Partner Stephen Kenny and William Godsave, Head of Financial Planning at Credo Wealth for an initial conversation.

Important Notice

This marketing material has been prepared and issued in the United Kingdom by Credo Capital Limited (“Credo”). It is provided to you for discussion purposes only and does not constitute and should not be interpreted as either investment advice (including legal, tax or accounting advice) or a trading recommendation. This marketing material is not a solicitation to buy or sell any financial instruments or commodities, a recommendation to participate in a particular trading strategy or to invest into regulated or unregulated funds. The value of an investment can fall as well as rise and is not guaranteed, your capital may be at risk and you may not receive back your original investment in full.

PKF Littlejohn is not licensed to provide financial advice. Whilst Credo is independent from PKF Littlejohn, through a joint venture owned by PKF Littlejohn and Credo, PKF is entitled to a proportion of all fees arising from any advice given by Credo. If you have any questions about the relationship between Credo and PKF Littlejohn please contact your usual PKF Littlejohn contact or Stephen Kenny.

Credo Capital Limited is a company registered in England and Wales, Company No: 03681529, whose registered office is 8-12 York Gate, 100 Marylebone Road, London, NW1 5DX. Authorised and regulated by the Financial Conduct Authority (FRN:192204). © 2024. Credo Capital Limited. All rights reserved.

Contact our experts